Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
1.130
-0.030 (-2.59%)
At close: Dec 5, 2025, 4:00 PM EST
1.122
-0.008 (-0.74%)
After-hours: Dec 5, 2025, 7:58 PM EST
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $25.31 million as of December 5, 2025. Its market cap has increased by 534.48% in one year.
Market Cap
25.31M
Enterprise Value
21.19M
1-Year Change
534.48%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $25.31M, a decrease of -61.23%. That is a compound annual growth rate of -20.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 25.31M | 534.48% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |